TB Alliance Launches Creator Collective to Highlight TB In the Global Conversation
Seven creators from around the world will partner with TB Alliance to connect new audiences with the people and science
Announcement
TB Alliance Announces Three Leadership Appointments
Carolyn Reynolds joins as Senior Vice President of External Affairs, Lynn Connolly as Chief Medical Officer, and Majda Benhayoun is
Doris Macharia Elected President of TB Alliance’s Global TB Stakeholders, Joins Board of Directors
Global health leader brings deep expertise in advancing children’s health, HIV, and global health equity NEW YORK (March 2, 2026)—TB
TB Alliance Joins Indonesia’s High-Level Meeting on TB
BALI, Indonesia (November 11, 2024)—TB Alliance is honored to join today’s High-Level Meeting hosted by the Indonesian Ministry of Health.
World Leaders Cite the Benefit and Importance of New, Six-Month Drug-Resistant TB Treatment at United Nations High-Level Meeting on Tuberculosis
The 2023 United Nations (UN) High-Level Meeting (HLM) on Tuberculosis (TB) saw world leaders come together to commit to increased
8 Things to Know about Drug-Resistant Tuberculosis
By: Sandeep Juneja, Senior Vice President, Market Access Drug-resistant tuberculosis (DR-TB) forms when long, complex, outdated drug regimens are improperly
TB Alliance Receives GHTC Partnership Award for Development of New TB Treatment
TB Alliance is honored to accept a 2022 Innovating for Impact Award WASHINGTON, DC (December 7, 2022)—At the sixth annual
At United Nations High Level Meeting, World Leaders Commit to Ending TB
Unfortunately, the recent history of the tuberculosis (TB) pandemic has in large part been defined by neglect—inadequate funding for research